Norinchukin Bank’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Buy |
3,705
+97
| +3% | +$21.2K | 0.01% | 447 |
|
|
2025
Q1 | $808K | Buy |
3,608
+457
| +15% | +$102K | 0.01% | 424 |
|
|
2024
Q4 | $1.03M | Buy |
3,151
+213
| +7% | +$69.8K | 0.02% | 352 |
|
|
2024
Q3 | $882K | Buy |
2,938
+361
| +14% | +$108K | 0.02% | 369 |
|
|
2024
Q2 | $849K | Buy |
2,577
+136
| +6% | +$44.8K | 0.02% | 333 |
|
|
2024
Q1 | $966K | Sell |
2,441
-29
| -1% | -$11.5K | 0.03% | 308 |
|
|
2023
Q4 | $870K | Sell |
2,470
-59
| -2% | -$20.8K | 0.02% | 320 |
|
|
2023
Q3 | $949K | Sell |
2,529
-798
| -24% | -$299K | 0.02% | 306 |
|
|
2023
Q2 | $1.27M | Sell |
3,327
-888
| -21% | -$340K | 0.02% | 380 |
|
|
2023
Q1 | $1.46M | Buy |
4,215
+142
| +3% | +$49.2K | 0.03% | 309 |
|
|
2022
Q4 | $959K | Sell |
4,073
-626
| -13% | -$147K | 0.02% | 371 |
|
|
2022
Q3 | $1.16M | Buy |
4,699
+351
| +8% | +$86.3K | 0.02% | 349 |
|
|
2022
Q2 | $1.32M | Sell |
4,348
-2,389
| -35% | -$723K | 0.03% | 316 |
|
|
2022
Q1 | $2.77M | Buy |
6,737
+454
| +7% | +$186K | 0.04% | 268 |
|
|
2021
Q4 | $2.95M | Sell |
6,283
-33
| -0.5% | -$15.5K | 0.04% | 238 |
|
|
2021
Q3 | $2.68M | Buy |
6,316
+197
| +3% | +$83.6K | 0.04% | 239 |
|
|
2021
Q2 | $2.2M | Sell |
6,119
-35
| -0.6% | -$12.6K | 0.03% | 267 |
|
|
2021
Q1 | $1.73M | Buy |
6,154
+104
| +2% | +$29.3K | 0.02% | 301 |
|
|
2020
Q4 | $1.71M | Sell |
6,050
-146
| -2% | -$41.4K | 0.02% | 279 |
|
|
2020
Q3 | $1.7M | Buy |
6,196
+95
| +2% | +$26.1K | 0.03% | 258 |
|
|
2020
Q2 | $1.39M | Buy |
+6,101
| New | +$1.39M | 0.02% | 286 |
|